Study Safety and Effectiveness of CURVE Laser Therapy for Circumference Reduction of the Waistline.

NCT ID: NCT02909790

Last Updated: 2016-09-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-05-31

Study Completion Date

2016-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess the safety and effectiveness of the CURVE Low-Level Laser Therapy for circumference reduction of the waistline.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study involves research to obtain information on the CURVE. In recent years Low Level Laser therapy devices have grown in popularity due to increased scientific understanding of their mechanism of action, published research, and patients demand for more non-invasive procedures in body contour and fat reduction. LLL are widely used in health clinics, medical spas and in aesthetic medicine in the treatment of cellulite and for inflammatory conditions such as carpal tunnel syndrome. This study will further evaluate the effectiveness of low-level laser treatments without the extraction of adipose tissue using liposuction or in combination with other treatment modalities.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Injury to Subcutaneous Tissue

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CURVE LLLT treatment

Up to 20 subjects are randomly selected to receive Curve Low Level Laser Therapy

Group Type EXPERIMENTAL

Curve Low Level Laser Therapy

Intervention Type DEVICE

Subjects assigned to the treatment group will be treated with 4 multi-paddle low-level diode laser consisting of 8 independent diode laser heads per treatment paddle, each emitting 630-680nm (red) laser light with each diode generating 40mW output ("CURVE" Laser - manufactured by YOLO Medical Inc.).

SHAM device treatment

Up to 20 subjects assigned to the sham group will be treated with a device that is designed to have the same physical appearance as the treatment group, except that the interlock fuse (grey fuse holder back of device) will be removed prior to treatment. The laser screen will still be active and show to the subject that the treatment time will still be counting down, but will not activate lasers in the treatment paddles

Group Type SHAM_COMPARATOR

Curve Low Level Laser Therapy

Intervention Type DEVICE

Subjects assigned to the treatment group will be treated with 4 multi-paddle low-level diode laser consisting of 8 independent diode laser heads per treatment paddle, each emitting 630-680nm (red) laser light with each diode generating 40mW output ("CURVE" Laser - manufactured by YOLO Medical Inc.).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Curve Low Level Laser Therapy

Subjects assigned to the treatment group will be treated with 4 multi-paddle low-level diode laser consisting of 8 independent diode laser heads per treatment paddle, each emitting 630-680nm (red) laser light with each diode generating 40mW output ("CURVE" Laser - manufactured by YOLO Medical Inc.).

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Subject is an adult ≥ 18 years old and \<65 years of age
2. Subject has maintained a stable weight for the past 6 months (variation no greater than 10 lbs. from "usual weight").
3. Subject is willing to maintain current diet and exercise regimen for the duration of study.
4. Subject is willing and able to provide written informed consent.
5. Subject is willing to return for all scheduled and required visits.
6. Subject is willing to comply with post-laser treatment cardiovascular exercise.
7. Subject is willing to comply with food and fluid requirements pre-treatment and post-treatment.

Exclusion Criteria

1. Subject is on an active weight control regimen.
2. Subject has a pacemaker.
3. Subject has a history of epilepsy.
4. Subject has a history of any type of cancer, including skin cancer.
5. Subject had a prior surgical intervention for body sculpting/weight loss such as liposuction, abdominoplasty, gastroplasty, lap band surgery, etc.
6. Subject has a medical, physical, or other contraindications for body sculpting/weight loss.
7. Subject has an active infection, wound or other external trauma to the areas to be treated with the laser.
8. Subject is pregnant, breast feeding, or planning pregnancy prior to study end.
9. Subject is participating in any treatment other than the study procedure (existing or new) to promote body contouring and/or weight loss during the course of study participation.
10. Subject is participating in another research study of a device, medication, biologic, or other agent within 30 days or could, in the opinion of the investigator, affect the results of this study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

64 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Yolo Medical Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Haneef Alibhai, MD

Role: PRINCIPAL_INVESTIGATOR

UBC Faculty of Medicine

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CCSP-2016- CURVE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Thigh Circumference Reduction Study
NCT00953290 TERMINATED NA
LED Device for Non-Invasive Lipolysis
NCT03171051 TERMINATED NA